Home › Funds › ProShare Advisors LLC › GILD

ProShare Advisors LLC position in GILD

GILEAD SCIENCES INC · Health Care

ProShare Advisors LLC reported holding 1,444,047 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$215.2M, representing 0.31% of its reported portfolio and ranking #47 among its reported holdings. ProShare Advisors LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.44M sh
Reported value held$215.24M
Portfolio Weight0.31%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How ProShare Advisors LLC's GILD position evolved

ProShare Advisors LLC first disclosed a stake in GILD in Q3 2023 at 1,431,276 shares (US$107.3M). The position peaked in Q2 2026 at 2,829,082 shares, worth US$357.4M. Across 13 filings, ProShare Advisors LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,444,047 shares valued at US$215.2M — a reduction of -1,385,035 shares quarter over quarter.. Notable position changes include a 39% increase in Q4 2025 (shares rose 14% over the following quarter), a 56% increase in Q2 2026 (shares rose 18% over the following quarter), a 49% trim in Q3 2026 (shares rose 13% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.43M $107.26M New
Q4 2023 1.22M $98.62M Reduce
Q1 2024 1.48M $108.48M Add
Q2 2024 1.35M $92.39M Reduce
Q3 2024 1.42M $119.21M Add
Q4 2024 1.65M $152.11M Add
Q1 2025 1.85M $207.62M Add
Q2 2025 1.95M $215.75M Add
Q3 2025 1.59M $176.88M Reduce
Q4 2025 2.22M $272.15M Add
Q1 2026 1.81M $252.43M Reduce
Q2 2026 2.83M $357.43M Add
Q3 2026 1.44M $215.24M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GILD and 13F data

GILD (GILEAD SCIENCES INC) is a Health Care company. 34 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.68B), Invesco Ltd (US$5.76B), Capital World Investors (US$5.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GILD

All GILD fund holders →

FAQ

How long has ProShare Advisors LLC held GILD?

ProShare Advisors LLC has disclosed GILD holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is ProShare Advisors LLC's current position in GILD?

As of Q3 2026, ProShare Advisors LLC holds 1.44M shares of GILD (GILEAD SCIENCES INC), valued at $215.24M, representing 0.31% of its reported portfolio and ranking #47.

Has ProShare Advisors LLC been buying or selling GILD?

In the latest 13F filing (Q3 2026), ProShare Advisors LLC reduced its position in GILD. The position peaked in Q2 2026 at 2.83M shares.

Which other funds hold GILD?

Other major institutional holders of GILD include Fidelity Management & Research (FMR), Invesco Ltd, Capital World Investors, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.